Geftib is a sort of medication called a tyrosine kinase inhibitor (TKI), otherwise called a tumor development inhibitor. Kinases are proteins in the body that control how the cells develop and isolate. Geftib pieces (restrains) the protein from sending signs to the disease cells that make them develop and separate.
Geftib is utilized to treat a few people with non-little cell lung growth (NSCLC). It works for tumors that have a strange type of a protein called epidermal development calculate receptor (EGFR). Tests are done on the disease cells from a lung biopsy or past surgery to check the level of EGFR.